サンドスタチンLAR薬の世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D09194)
◆英語タイトル:Global Sandostatin LAR Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D09194
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年11月9日(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、サンドスタチンLAR薬の世界市場について調査・分析し、種類別には、500mcg、1000mcg、その他に、用途別には、腫瘍、食道静脈瘤出血、その他に区分してまとめました。調査対象企業は、Novartis等です。

・レポートの概要
・グローバル成長トレンド
・サンドスタチンLAR薬の世界市場規模
・サンドスタチンLAR薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別サンドスタチンLAR薬の価格動向
・サンドスタチンLAR薬の種類別市場規模(500mcg、1000mcg、その他)
・サンドスタチンLAR薬の用途別市場規模(腫瘍、食道静脈瘤出血、その他)
・サンドスタチンLAR薬の北米市場(アメリカ、カナダ、メキシコ)
・サンドスタチンLAR薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・サンドスタチンLAR薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・サンドスタチンLAR薬の中南米市場(ブラジル等)
・サンドスタチンLAR薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Novartis)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・サンドスタチンLAR薬の市場規模予測
・サンドスタチンLAR薬の種類別市場予測2018-2025(500mcg、1000mcg、その他)
・サンドスタチンLAR薬の用途別市場予測2018-2025(腫瘍、食道静脈瘤出血、その他)
・サンドスタチンLAR薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・サンドスタチンLAR薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・サンドスタチンLAR薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・サンドスタチンLAR薬の中南米市場予測2018-2025(ブラジル等)
・サンドスタチンLAR薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone.In 2018, the global Sandostatin LAR Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Sandostatin LAR Drugs.

This study researches the market size of Sandostatin LAR Drugs, presents the global Sandostatin LAR Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Sandostatin LAR Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Sandostatin LAR Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Novartis

Market Segment by Product Type
500mcg
1000mcg
Other

Market Segment by Application
Tumors
Bleeding Esophageal Varices
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Sandostatin LAR Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Sandostatin LAR Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Sandostatin LAR Drugs are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Sandostatin LAR Drugs Market Size Growth Rate by Type
1.3.2 500mcg
1.3.3 1000mcg
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Sandostatin LAR Drugs Market Share by Application (2018-2025)
1.4.2 Tumors
1.4.3 Bleeding Esophageal Varices
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Sandostatin LAR Drugs Market Size
2.1.1 Global Sandostatin LAR Drugs Revenue 2013-2025
2.1.2 Global Sandostatin LAR Drugs Sales 2013-2025
2.2 Sandostatin LAR Drugs Growth Rate by Regions
2.2.1 Global Sandostatin LAR Drugs Sales by Regions 2013-2018
2.2.2 Global Sandostatin LAR Drugs Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Sandostatin LAR Drugs Sales by Manufacturers
3.1.1 Sandostatin LAR Drugs Sales by Manufacturers 2013-2018
3.1.2 Sandostatin LAR Drugs Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Sandostatin LAR Drugs Revenue by Manufacturers (2013-2018)
3.2.2 Sandostatin LAR Drugs Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Sandostatin LAR Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Sandostatin LAR Drugs Price by Manufacturers
3.4 Key Manufacturers Sandostatin LAR Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Sandostatin LAR Drugs Market
3.6 Key Manufacturers Sandostatin LAR Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 500mcg Sales and Revenue (2013-2018)
4.1.2 1000mcg Sales and Revenue (2013-2018)
4.1.3 Other Sales and Revenue (2013-2018)
4.2 Global Sandostatin LAR Drugs Sales Market Share by Type
4.3 Global Sandostatin LAR Drugs Revenue Market Share by Type
4.4 Sandostatin LAR Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Sandostatin LAR Drugs Sales by Application

6 North America
6.1 North America Sandostatin LAR Drugs Breakdown Data by Company
6.2 North America Sandostatin LAR Drugs Breakdown Data by Type
6.3 North America Sandostatin LAR Drugs Breakdown Data by Application
6.4 North America Sandostatin LAR Drugs Breakdown Data by Countries
6.4.1 North America Sandostatin LAR Drugs Sales by Countries
6.4.2 North America Sandostatin LAR Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Sandostatin LAR Drugs Breakdown Data by Company
7.2 Europe Sandostatin LAR Drugs Breakdown Data by Type
7.3 Europe Sandostatin LAR Drugs Breakdown Data by Application
7.4 Europe Sandostatin LAR Drugs Breakdown Data by Countries
7.4.1 Europe Sandostatin LAR Drugs Sales by Countries
7.4.2 Europe Sandostatin LAR Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Sandostatin LAR Drugs Breakdown Data by Company
8.2 Asia Pacific Sandostatin LAR Drugs Breakdown Data by Type
8.3 Asia Pacific Sandostatin LAR Drugs Breakdown Data by Application
8.4 Asia Pacific Sandostatin LAR Drugs Breakdown Data by Countries
8.4.1 Asia Pacific Sandostatin LAR Drugs Sales by Countries
8.4.2 Asia Pacific Sandostatin LAR Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Sandostatin LAR Drugs Breakdown Data by Company
9.2 Central & South America Sandostatin LAR Drugs Breakdown Data by Type
9.3 Central & South America Sandostatin LAR Drugs Breakdown Data by Application
9.4 Central & South America Sandostatin LAR Drugs Breakdown Data by Countries
9.4.1 Central & South America Sandostatin LAR Drugs Sales by Countries
9.4.2 Central & South America Sandostatin LAR Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Sandostatin LAR Drugs Breakdown Data by Type
10.2 Middle East and Africa Sandostatin LAR Drugs Breakdown Data by Application
10.3 Middle East and Africa Sandostatin LAR Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Sandostatin LAR Drugs Sales by Countries
10.3.2 Middle East and Africa Sandostatin LAR Drugs Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Sandostatin LAR Drugs
11.1.4 Sandostatin LAR Drugs Product Introduction
11.1.5 Novartis Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Sandostatin LAR Drugs Sales Channels
12.2.2 Sandostatin LAR Drugs Distributors
12.3 Sandostatin LAR Drugs Customers

13 Market Forecast
13.1 Global Sandostatin LAR Drugs Sales and Revenue Forecast 2018-2025
13.2 Global Sandostatin LAR Drugs Sales Forecast by Type
13.3 Global Sandostatin LAR Drugs Sales Forecast by Application
13.4 Sandostatin LAR Drugs Forecast by Regions
13.4.1 Global Sandostatin LAR Drugs Sales Forecast by Regions 2018-2025
13.4.2 Global Sandostatin LAR Drugs Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Sandostatin LAR Drugs Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Sandostatin LAR Drugs Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Sandostatin LAR Drugs Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Sandostatin LAR Drugs Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Sandostatin LAR Drugs Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Novartis

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ サンドスタチンLAR薬の世界市場動向・分析2018-2025(Global Sandostatin LAR Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。